Immunicum AB News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

24.05.18	Immunicum AB: Invitation to Investor Event (GlobeNewswire)
21.05.18	Immunicum AB (publ) Announces End of Enrollment in Phase I/II GIST Clinical Trial (GlobeNewswire)
14.05.18	Immunicum AB (publ) Announces Upcoming Presentations and Attendances at Conferences in May and June (GlobeNewswire)
04.05.18	Immunicum AB (publ) Interim report January - March 2018 (GlobeNewswire)
25.04.18	Report from the Annual General Meeting of Immunicum AB (publ) on April 25, 2018 (GlobeNewswire)
03.04.18	Immunicum AB (publ) Publishes the Annual Report for 2017 (GlobeNewswire)
03.04.18	Immunicum AB (publ) Provides Update on Ilixadencel Clinical Development Program (GlobeNewswire)
26.03.18	Notice of Annual General Meeting in Immunicum AB (publ) (GlobeNewswire)
21.03.18	Immunicum AB: Invitation to Investor Events (GlobeNewswire)
20.03.18	Immunicum AB: Immunicum AB (publ) Announces ATMP Certificate Granted by EMA to Ilixadencel for Manufacturing Quality and Non-clinical Data (GlobeNewswire)
14.03.18	Immunicum AB: The Nomination Committee of Immunicum AB (publ) proposes Michael Oredsson as new Chairman of the Board (GlobeNewswire)
16.02.18	Immunicum AB (publ) Year-End Report (October - December 2017) Corporate Update and Outlook (GlobeNewswire)
05.02.18	Immunicum AB (publ) Presents Case Study of One Patient from Phase I/II HCC Trial at Cholangiocarcinoma Foundation Annual Conference (GlobeNewswire)
31.01.18	Michaela Gertz Joins Immunicum as CFO (GlobeNewswire)
31.01.18	Change in the Number of Shares and Votes in Immunicum (GlobeNewswire)
22.01.18	Immunicum AB (publ) Announces Upcoming Presentations and Attendances at Conferences in January and February (GlobeNewswire)
15.01.18	Immunicum AB (publ) Initiates Trading of Shares on Nasdaq Stockholm (GlobeNewswire)
08.01.18	Immunicum AB (publ) Announces Completion of Patient Recruitment for Phase II MERECA Trial (GlobeNewswire)
29.12.17	Immunicum AB (publ) Announces the Outcome of the Rights Issue (GlobeNewswire)
05.12.17	Immunicum AB Publishes Prospectus in Connection with Rights Issue and Listing on Nasdaq Stockholm (GlobeNewswire)
04.12.17	Immunicum Announces Report from the Extraordinary General Meeting on December 4, 2017 (GlobeNewswire)
27.11.17	Immunicum Announces Positive Preliminary Results from Proof-of-Concept Animal Study Testing Combination of Ilixadencel and Checkpoint Inhibitors (GlobeNewswire)
24.11.17	Nasdaq Stockholm's Listing Committee Has Approved Immunicum's Shares for Listing on Nasdaq Stockholm Conditional Upon Completion of the Rights Issue (GlobeNewswire)
22.11.17	Immunicum AB: Invitation to Investor Events (GlobeNewswire)
17.11.17	Immunicum AB (publ): Interim Report Q3 - Corporate Update and Outlook (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Immunicum AB

Aktien Top/Flop

Meistgelesene Nachrichten